ClinicalTrials.Veeva

Menu

Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis (NANO-RAST)

R

Resistell

Status

Completed

Conditions

Bacteremia Sepsis

Treatments

Diagnostic Test: Resistell AST

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05002413
2020-01622

Details and patient eligibility

About

Blood culture samples from bacteremia patients positive for Gram-negative bacteria will be tested for antibacterial susceptibility using Resistell Phenotech device. The results will be compared with current AST gold standard tests to calculate sensitivity, specificity, and accuracy of Resistell Phenotech device.

Full description

NANO-RAST: Nano-motion based Resistell AST to determine the antibiotic susceptibility of bacteria causing bacteremia and sepsis.

Study population: patients admitted at the study site with bacteremia considered to be due to a pathogenic strain (E. coli or K. pneumoniae).

Study design: prospective, observational, single arm study.

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: The patients meeting all the following criteria can be recruited in the study:

  • patients over the age of 18 years who sign, or their relatives / legal representatives sign the informed consent form;
  • patients with bacteremia considered to be due to a pathogenic strain;
  • patients hospitalized at CHUV at the time of blood culture inoculation;
  • patients whose positive blood cultures were not older than 24 hours at the time of AST start.

Exclusion Criteria The patients meeting any of the following criteria will be excluded from the study:

  • patient is diagnosed with polymicrobial bacteremia;
  • samples can be excluded from the study during the processing of samples in case of technical errors e.g. failure with attachment of cells, technical problem with the device or sensor, operator's error, etc.

Note: in the event that the capacity of the Resistell instruments is reached for the day, no more ICFs will be obtained for the day.

Trial contacts and locations

1

Loading...

Central trial contact

Danuta Cichocka, Dr; Clara Orlando, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems